Abiomed Inc (ABMD) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abiomed Inc   (NASDAQ: ABMD)


Abiomed Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abiomed Inc's ROI in the second quarter of 2023?
Abiomed Inc achieved a return on average invested assets (ROI) of 17.42 % in its second quarter of 2023, which is below Abiomed Inc's average return on investment, which stands at 19.42%.

ROI has improved compared to 14.56% in the first quarter of 2023, due to net income growth.

Within the Healthcare sector 70 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2022 quarter, so far to 493, from total ROI ranking in the first quarter of 2023 at 553.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter		 (Sep 30 2021)
II. Quarter
Y / Y Investment Change TTM 12.83 % 14.25 % 14.68 % 17.88 % 20.4 %
Y / Y Net Income Change TTM 78.85 % 40.91 % -24.56 % 7.22 % 139.74 %
Investment (TTM) in Millions 1,562 1,562 1,534 1,465 1,415
Return On Investment (TTM) 17.42 % 14.56 % 9.48 % 9.52 % 10.99 %
ABMD's Overall Ranking # 493 # 553 # 1442 # 1478 # 1106
Seq. Investment Change TTM 2.46 % 3.78 % 3.03 % 2.98 % 3.76 %
Seq. Net Income Change TTM 22.6 % 59.4 % 2.61 % -10.81 % -3.41 %
Net Income (TTM) in Millions 267 218 137 133 149

ABMD Company Profile >> Back to ABMD Roi Comparisons >> See Annual ABMD Return On Investment



Return On Investment ABMD's Ranking
Within: No.
Industry # 15
Sector # 71
Overall # 493

Return On Investment Statistics
High Average Low
52.03 %
19.42 %
4.36 %
(March 31, 2015)   (June 30. 2014)







Financial Statements
Abiomed Inc's II. Quarter Investments $ 1,562 Millions ABMD's Balance sheet
Abiomed Inc's II. Quarter Income $ 106 Millions Quarterly ABMD's Income Statement
ABMD's Income by Division See ABMD's Income by Division


ABMD Annual Return On Investment (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019		 (Mar 31 2018)
2018
Total Investments in Millions 1,534 1,365 1,085 948 702
Y / Y Investment Growth 12.43 % 25.81 % 14.36 % 35.15 % 45.94 %
Net Income in Millions 137 226 203 259 112
Y / Y Net Income Growth -39.47 % 11.09 % -21.62 % 130.91 % 115.23 %
Annual Return On Investment 8.9 % 16.53 % 18.72 % 27.31 % 15.99 %


Annual Roi Comment
In the fiscal year 2022 ROI decreased relative to the previous year to 8.9 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABMD's Competitors
Subscribers only: Roi for Abiomed Inc's Suppliers
Subscribers only: Return On Investment for ABMD's Customers

Other Ratios
ABMD's Roa ABMD's Inventory Turnover Ratio ABMD's Growth Rates ABMD's Dividend Statistics
ABMD's Profitability Ratios ABMD's Asset Turnover Ratio ABMD's Dividend Growth
ABMD's Roe ABMD's Valuation Ratios ABMD's Financial Strength Ratios ABMD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI
Journey Medical Corp  45.06 %
Biofrontera Inc   44.78 %
Idexx Laboratories Inc  41.99 %
REST EZ Inc.  41.68 %
Iteos Therapeutics Inc   40.85 %
Prophase Labs Inc   39.24 %
Mettler toledo International Inc   38.09 %
Orgenesis Inc   37.05 %
Vicarious Surgical Inc  36.26 %
Harmony Biosciences Holdings inc   35.33 %
Nrc Health  33.19 %
Exelixis Inc   32.97 %
Avid Bioservices Inc   32.85 %
Embecta Corp   31.85 %
Cartesian Therapeutics Inc   31.06 %
Innoviva Inc   29.72 %
Catalyst Pharmaceuticals Inc   27.65 %
Corcept Therapeutics Inc  27.25 %
Medpace Holdings Inc   27.00 %
Ir med Inc   26.71 %
Vertex Pharmaceuticals Inc  25.93 %
Aptevo Therapeutics Inc   25.88 %
Dariohealth Corp   25.43 %
Semler Scientific inc   25.41 %
Shockwave Medical Inc   25.37 %
Gyre Therapeutics Inc   24.33 %
Lftd Partners Inc   24.03 %
Skinhealth Systems Inc   23.61 %
Regeneron Pharmaceuticals Inc   23.50 %
Maravai Lifesciences Holdings Inc   23.20 %

Date modified: 2026-08-29T17:31:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.